Precision BioSciences is developing mulitple DNE therapeutics targeted to enable the precise in situ correction of genes responsible for human disease.
More about BioTherapeutics >>
Engineered DNE meganucleases are being used to engineer cell lines for disease models or optimize cell lines for the biomanufacturing of protein vaccines and therapeutics.
More about BioTools >>
Custom DNE meganucleases produced by Precision BioSciences enable site-specific engineering of row crops and biofuel feedstocks.
More about PlantSciences >>
Precision BioSciences Announces Victory in Challenge to Genome Engineering Patent
Danziger Innovations and Precision BioSciences Announce Successful Genome Modification Collaboration in Ornamental Plants
Precision BioSciences and DuPont Detail Technology Efficacy in The Plant Journal